FI960977A - Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet - Google Patents
Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet Download PDFInfo
- Publication number
- FI960977A FI960977A FI960977A FI960977A FI960977A FI 960977 A FI960977 A FI 960977A FI 960977 A FI960977 A FI 960977A FI 960977 A FI960977 A FI 960977A FI 960977 A FI960977 A FI 960977A
- Authority
- FI
- Finland
- Prior art keywords
- pct
- proteins
- noncellular
- exported proteins
- bacterial origin
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 230000001580 bacterial effect Effects 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000192125 Firmicutes Species 0.000 abstract 1
- 108091005461 Nucleic proteins Proteins 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/03—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with oxygen as acceptor (1.2.3)
- C12Y102/03003—Pyruvate oxidase (1.2.3.3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11654193A | 1993-09-01 | 1993-09-01 | |
| US08/245,511 US5928900A (en) | 1993-09-01 | 1994-05-18 | Bacterial exported proteins and acellular vaccines based thereon |
| PCT/US1994/009942 WO1995006732A2 (en) | 1993-09-01 | 1994-09-01 | Bacterial exported proteins and acellular vaccines based thereon |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI960977A0 FI960977A0 (fi) | 1996-03-01 |
| FI960977A true FI960977A (fi) | 1996-04-30 |
Family
ID=26814346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI960977A FI960977A (fi) | 1993-09-01 | 1996-03-01 | Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5928900A (fi) |
| EP (1) | EP0721506B1 (fi) |
| JP (1) | JP3722834B2 (fi) |
| AT (1) | ATE332376T1 (fi) |
| AU (1) | AU709405B2 (fi) |
| CA (1) | CA2170726A1 (fi) |
| DE (1) | DE69434784T2 (fi) |
| DK (1) | DK0721506T3 (fi) |
| ES (1) | ES2267096T3 (fi) |
| FI (1) | FI960977A (fi) |
| NO (1) | NO321826B1 (fi) |
| NZ (1) | NZ273497A (fi) |
| PT (1) | PT721506E (fi) |
| WO (1) | WO1995006732A2 (fi) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2638595A (en) * | 1994-05-16 | 1995-12-05 | Uab Research Foundation, The | (streptococcus pneumoniae) capsular polysaccharide genes and flanking regions |
| US6245335B1 (en) | 1996-05-01 | 2001-06-12 | The Rockefeller University | Choline binding proteins for anti-pneumococcal vaccines |
| US5834278A (en) * | 1996-05-01 | 1998-11-10 | The Rockefeller University | Bacterial peptide methionine sulfoxide reductase an adhesion-associated protein, and antibiotic therapies based thereon |
| US6165989A (en) | 1996-05-14 | 2000-12-26 | Smithkline Beecham Corporation | Era of Streptococcus pneumoniae |
| JP2000514308A (ja) * | 1996-08-16 | 2000-10-31 | スミスクライン・ビーチャム・コーポレイション | 新規原核生物ポリヌクレオチド、ポリペプチドおよびそれらの使用 |
| US5882896A (en) * | 1996-09-24 | 1999-03-16 | Smithkline Beecham Corporation | M protein |
| US5882871A (en) * | 1996-09-24 | 1999-03-16 | Smithkline Beecham Corporation | Saliva binding protein |
| US5928895A (en) * | 1996-09-24 | 1999-07-27 | Smithkline Beecham Corporation | IgA Fc binding protein |
| US6420135B1 (en) | 1996-10-31 | 2002-07-16 | Human Genome Sciences, Inc. | Streptococcus pneumoniae polynucleotides and sequences |
| JP2002503087A (ja) | 1996-11-12 | 2002-01-29 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | ストレプトコッカス・ニューモニアのｃ３結合タンパク質 |
| US20040242522A1 (en) * | 1997-02-14 | 2004-12-02 | Volkin David B. | Polynucleotide vaccine formulations |
| US6676943B1 (en) | 1997-04-24 | 2004-01-13 | Regents Of The University Of Minnesota | Human complement C3-degrading protein from Streptococcus pneumoniae |
| CA2341268C (en) * | 1998-07-22 | 2010-10-12 | Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. | Streptococcus suis vaccines and diagnostic tests |
| US20030134407A1 (en) | 1998-07-27 | 2003-07-17 | Le Page Richard William Falla | Nucleic acids and proteins from Streptococcus pneumoniae |
| EP1801218A3 (en) * | 1998-07-27 | 2007-10-10 | Sanofi Pasteur Limited | Nucleic acids and proteins from streptococcus pneumoniae |
| US6936252B2 (en) | 1998-07-27 | 2005-08-30 | Microbial Technics Limited | Streptococcus pneumoniae proteins and nucleic acid molecules |
| CN1318103A (zh) * | 1998-07-27 | 2001-10-17 | 微生物技术有限公司 | 肺炎链球菌的核酸和蛋白质 |
| JP2002531055A (ja) * | 1998-07-27 | 2002-09-24 | マイクロビアル テクニクス リミティッド | 肺炎連鎖球菌のタンパク質及び核酸分子 |
| JP2002531054A (ja) * | 1998-07-27 | 2002-09-24 | マイクロビアル テクニクス リミティッド | Ｂ群連鎖球菌由来の核酸およびタンパク質 |
| EP1790730A3 (en) * | 1998-07-27 | 2007-09-12 | Sanofi Pasteur Limited | Streptococcus pneumoniae proteins and nucleic acid molecules |
| EP1624064A3 (en) * | 1998-07-27 | 2006-05-10 | Microbial Technics Limited | Nucleic acids and proteins from streptococcus pneumoniae |
| US7098182B2 (en) | 1998-07-27 | 2006-08-29 | Microbial Technics Limited | Nucleic acids and proteins from group B streptococcus |
| EP1140157B1 (en) | 1998-12-21 | 2009-02-18 | MedImmune, Inc. | Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| GB9921125D0 (en) * | 1999-09-07 | 1999-11-10 | Microbial Technics Limited | Proteins |
| JP2003531149A (ja) * | 2000-04-13 | 2003-10-21 | ザ・ロツクフエラー・ユニバーシテイ | 抗体由来の免疫応答の増強 |
| EP1205552A1 (en) | 2000-11-09 | 2002-05-15 | ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. | Virulence of streptococci, involving ORFs from Streptococcus suis |
| JP4275413B2 (ja) * | 2001-02-02 | 2009-06-10 | イーデー−レーリスタット，インスティチュート フォール ディールハウデレイ エン ディールゲゾントヘイト ベー．フェー． | ストレプトコッカス・スイスの環境的に調節された遺伝子 |
| US20030082595A1 (en) * | 2001-08-03 | 2003-05-01 | Bo Jiang | Nucleic acids of aspergillus fumigatus encoding industrial enzymes and methods of use |
| NO20026286D0 (no) * | 2002-12-30 | 2002-12-30 | Amersham Health As | Nye peptider |
| EP2023143A1 (en) * | 2007-08-06 | 2009-02-11 | Boehringer Ingelheim Vetmedica Gmbh | Immunogenic streptococcus proteins |
| EP2897638A1 (en) | 2012-09-24 | 2015-07-29 | Montana State University-Bozeman | Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3886225T2 (de) * | 1987-01-06 | 1994-03-31 | Asahi Chemical Ind | Pyruvat-Oxidase, ihre Herstellung und Verwendung. |
| AU626961B2 (en) * | 1988-12-16 | 1992-08-13 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur | Pneumolysin mutants and pneumococcal vaccines made therefrom |
| WO1992014488A1 (en) * | 1991-02-15 | 1992-09-03 | Uab Research Foundation | Structural gene of pneumococcal protein |
| WO1993010238A1 (en) * | 1991-11-14 | 1993-05-27 | The Government Of The United States Of America As Represented By The Department Of Health And Human Services | Pneumococcal fimbrial protein a vaccines |
| EP0672123A1 (en) * | 1992-01-08 | 1995-09-20 | The Rockefeller University | Multifunctional surface protein of streptococci |
-
1994
- 1994-05-18 US US08/245,511 patent/US5928900A/en not_active Expired - Lifetime
- 1994-09-01 NZ NZ273497A patent/NZ273497A/en unknown
- 1994-09-01 ES ES94927328T patent/ES2267096T3/es not_active Expired - Lifetime
- 1994-09-01 AU AU76809/94A patent/AU709405B2/en not_active Expired
- 1994-09-01 US US08/600,993 patent/US5981229A/en not_active Expired - Lifetime
- 1994-09-01 CA CA002170726A patent/CA2170726A1/en not_active Abandoned
- 1994-09-01 JP JP50828795A patent/JP3722834B2/ja not_active Expired - Lifetime
- 1994-09-01 PT PT94927328T patent/PT721506E/pt unknown
- 1994-09-01 WO PCT/US1994/009942 patent/WO1995006732A2/en active IP Right Grant
- 1994-09-01 DE DE69434784T patent/DE69434784T2/de not_active Expired - Lifetime
- 1994-09-01 AT AT94927328T patent/ATE332376T1/de not_active IP Right Cessation
- 1994-09-01 EP EP94927328A patent/EP0721506B1/en not_active Expired - Lifetime
- 1994-09-01 DK DK94927328T patent/DK0721506T3/da active
-
1996
- 1996-02-29 NO NO19960839A patent/NO321826B1/no not_active IP Right Cessation
- 1996-03-01 FI FI960977A patent/FI960977A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ273497A (en) | 1998-03-25 |
| NO321826B1 (no) | 2006-07-10 |
| DE69434784T2 (de) | 2007-06-14 |
| EP0721506B1 (en) | 2006-07-05 |
| WO1995006732A2 (en) | 1995-03-09 |
| EP0721506A1 (en) | 1996-07-17 |
| ES2267096T3 (es) | 2007-03-01 |
| NO960839D0 (no) | 1996-02-29 |
| DE69434784D1 (de) | 2006-08-17 |
| NO960839L (no) | 1996-04-19 |
| US5981229A (en) | 1999-11-09 |
| US5928900A (en) | 1999-07-27 |
| WO1995006732A3 (en) | 1995-06-01 |
| FI960977A0 (fi) | 1996-03-01 |
| JPH09504686A (ja) | 1997-05-13 |
| JP3722834B2 (ja) | 2005-11-30 |
| DK0721506T3 (da) | 2006-10-30 |
| AU7680994A (en) | 1995-03-22 |
| AU709405B2 (en) | 1999-08-26 |
| PT721506E (pt) | 2006-10-31 |
| CA2170726A1 (en) | 1995-03-09 |
| ATE332376T1 (de) | 2006-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI960977A0 (fi) | Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet | |
| ZA954641B (en) | Polynucleotide vaccine for papilloma virus | |
| GEP20032977B (en) | Proteinase K-Resistant Surface Protein of Neisseria Meningitidis | |
| EA200100565A1 (ru) | Новые стрептококковые антигены | |
| EP0692031A4 (en) | HETEROLOGOUS ANTIGENS PRESENT IN VACCINE STRAINS WITH LIVING CELLS | |
| AU1915995A (en) | Active immunization using a siderophore receptor protein | |
| EP2141227A3 (en) | Hyperblebbing bacterial strains and use thereof for production of vaccines | |
| DK22389D0 (da) | Fremgangsmaade og middel til beskyttelse mod sygdomme foraarsaget af mikroorganismer, navnlig mycoplasma | |
| CA2022420A1 (en) | Escherichia coli vaccine | |
| PL303482A1 (en) | Vaccine against infection with streptococcus suis, streptococcus suis polypeptide and method of preparing such vaccine | |
| DK0418945T3 (da) | Forgreningsenzym og dets anvendelse | |
| EA200100700A1 (ru) | Гены и белки и их применение | |
| BRPI0309001A2 (pt) | bactérias gram-negativas atenuadas | |
| DK0840792T3 (da) | (S)-hydroxynitrillyase fra Hevea brasiliensis | |
| DE10399019I2 (de) | Gefl}gelkrankheit verursachende neue Bakterie und daraus stammender Impfstoff. | |
| AU673344B2 (en) | Vaccines based on streptokinase | |
| NZ295877A (en) | A vaccine comprising the helicobacter bacterium and its use | |
| DE60114876D1 (de) | DEKONTAMINATION VON PRIONHALTIGEM (z.B. BSE-AGENS ENTHALTENDEM) TIERFUTTER | |
| HUP9803007A1 (hu) | Aujeszky-féle betegség elleni, fokozott immunizáló képességgel rendelkező, élő- vagy inaktivált vírust tartalmazó oltóanyag és eljárás az oltóanyag előállítására |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |